Consumer DNA Test vs. Whole Genome Sequencing

Medically reviewed by Eland Siddle, PharmD · Last updated July 2026

Consumer DNA kits like 23andMe and AncestryDNA are convenient and affordable, and they can tell you interesting things about your ancestry and a handful of trait predispositions. What they cannot do is serve as a clinical diagnostic tool. Understanding why comes down to a single number: they examine roughly 0.02% of your genome.

Whole genome sequencing (WGS) reads all of it. Every base pair. That difference in coverage is the reason WGS can detect rare variants and conditions that genotyping-based consumer tests will always miss.

This article breaks down how each technology works, what each is genuinely useful for, and where the lines are between consumer-grade and clinical-grade testing.

How consumer DNA tests work

Most consumer DNA kits use a technology called genotyping, or SNP array testing. Rather than reading your entire genome, the chip checks a predetermined list of about 500,000 to 700,000 positions in your DNA, spots where people are known to vary from one another. These are called single nucleotide polymorphisms, or SNPs (pronounced "snips").

Your genome contains roughly 3 billion base pairs. Checking 700,000 of them means a consumer test is looking at less than one-tenth of one percent of your genetic code. That is by design: SNP arrays are fast, cheap, and well-suited to population-level ancestry inference and broad trait associations. They were built for that purpose.

The tradeoff is meaningful. Because the chip only checks known positions, it cannot find:

• Rare or novel variants (mutations not already catalogued in the array's reference list)
• Structural variants (larger rearrangements, deletions, or duplications in the genome)
• Copy number variants (CNVs) (regions where you have too few or too many copies of a gene segment)
• Variants in regions the chip was not designed to probe

Consumer tests also operate in a non-clinical context. Results are not validated for diagnostic use, labs running them are not required to meet CLIA certification standards for clinical reporting, and the reports are explicitly labeled as not intended for medical decision-making.

How whole genome sequencing works

WGS does not check a list of known positions. It reads every base pair in the genome from scratch, all approximately 3 billion of them. The result is a complete genetic blueprint, not a summary of selected landmarks.

Because nothing is pre-selected, WGS can detect:

• Common variants (everything a SNP chip would find, and more)
• Rare and novel variants (mutations that have never been catalogued before)
• Structural and copy number variants (large-scale changes that genotyping chips cannot resolve)
• Variants across the full genome (not just regions chosen at array design time)

When performed in a CLIA-certified, CAP-accredited laboratory and interpreted by qualified professionals, WGS produces clinically validated results, meaning they meet the standards required for use in medical decision-making. Learn more about what whole genome sequencing is and how it works.

Consumer DNA test vs. WGS: at a glance

What consumer tests are genuinely good for

Consumer DNA tests are excellent tools for what they were designed to do. Ancestry composition, genealogy matching, and exploring broad population genetics are all reasonable use cases. Some kits include trait reports (eye color tendencies, caffeine metabolism) that are curiosity-level insights, not medical findings.

A few consumer tests include FDA-authorized health reports for a small number of conditions (BRCA1/2 variants, for example). These are real data points, but they check only a handful of the known variants for those genes. A negative result does not mean no risk; it means the specific variants tested were not found. Clinicians typically recommend confirmatory testing before acting on any consumer test result.

If your interest is ancestry or family history curiosity, a consumer kit is a fine starting point. If your goal is to understand your child's health risks or medication responses, the technology is not designed for that purpose. For a deeper look at how ancestry-focused testing differs from clinical genetic testing, see our article on ancestry DNA vs. clinical genetic testing.

When whole genome sequencing is the right tool

WGS becomes relevant when the goal is clinical: when the results will inform medical decisions, guide treatment, or screen for health conditions. Physicians and genetic counselors use WGS in diagnostic workups for complex or undiagnosed conditions, and increasingly in proactive health screening contexts.

Because WGS reads the entire genome, it is also better positioned to remain useful over time. As researchers discover new gene-condition associations, a stored WGS dataset can be re-analyzed against updated knowledge without requiring a new sample. That is not possible with a SNP chip, which only captured the positions it was designed to check.

Wondering if proactive genetic screening makes sense for your child? This article walks through what parents should weigh.

Where Fore fits

Fore Genomics is a pediatric genetic health screen built on whole genome sequencing, not a panel, not a SNP array. The screen sequences 100% of a child's DNA and checks for 1,000+ genetic conditions and 100+ medication interactions. It is the only pediatric product on the market using WGS rather than a gene panel.

The process is straightforward: an at-home cheek swab, no clinic visit required. Results are interpreted in a CLIA-certified and CAP-accredited lab. Every screen includes board-certified genetic counseling to walk through results and discuss next steps. And because the full genome is stored, Fore offers lifetime reanalysis, so the same sample can be re-interpreted as genetic science advances, at no additional cost.

For parents who want to understand what genetic health screening actually involves before deciding, this guide for new parents is a good place to start.

Ready to learn what your child's genome can reveal? Explore Fore's at-home pediatric screen.

Personalized Care, Not Prediction

The difference between a consumer DNA kit and clinical sequencing is really a difference in what you can act on.

Traditional medicine tends to ask one question: is my child sick? Fore is built around a different one: how do we help keep them healthy? That shift matters, because a genetic finding is not a diagnosis.

• A variant is not a verdict. Most children who carry one will never develop the associated condition.
• It points to personalized care, not a fixed fate. A finding identifies who may benefit from closer attention, not who is destined to get sick.
• It gives your pediatrician a head start. Depending on the finding, that can mean earlier eye or hearing exams, periodic heart monitoring, earlier cholesterol screening, avoiding a specific medication, or simply noting the result to watch over time.
• The goal isn't predicting the future. It's making your child's care more personalized from day one.

Fore's at-home whole genome screen covers 1,000+ conditions and 100+ medication responses, includes board-certified genetic counseling, and reanalyzes your child's genome over time as science advances. See what Fore screens for.

FAQs

Can I use a 23andMe or AncestryDNA result for medical decisions?

Not directly. Consumer DNA test results are not clinically validated for diagnosis and are explicitly not intended for medical use. If a consumer test flags something concerning, a physician or genetic counselor will typically recommend confirmatory testing through a CLIA-certified lab before any clinical action is taken.

Does whole genome sequencing replace a consumer DNA test for ancestry?

WGS contains all the data a consumer ancestry test would find, and far more. But most WGS-based health screen programs are focused on clinical interpretation rather than ancestry reporting. If ancestry is your primary interest, a consumer kit is purpose-built for that. If health screening is the goal, WGS is the more appropriate tool.

Is whole genome sequencing covered by insurance?

Coverage varies widely by plan, indication, and provider. Diagnostic WGS ordered by a physician for a specific clinical concern has more established coverage pathways than proactive screening. Check with your insurance plan directly, and consult with a genetic counselor about the right testing approach for your situation.

Why does genome coverage percentage matter so much?

The vast majority of rare disease-causing variants are not on consumer SNP chip arrays. They are either in unchecked regions or are novel mutations not yet catalogued. A test that checks 0.02% of the genome will miss most of what clinical WGS would find. For health screening purposes, coverage is the single most important technical difference between these two approaches.

Do I need a doctor to order whole genome sequencing?

It depends on the program. Some clinical WGS services require a physician referral; others, like Fore's at-home screen, can be ordered directly by parents with genetic counseling built into the process. Always review results with a qualified professional before making any medical decisions.